Skin lighteners and hair relaxers as risk factors for breast cancer: results from the Ghana breast health study. 2018

Louise A Brinton, and Jonine D Figueroa, and Daniel Ansong, and Kofi M Nyarko, and Seth Wiafe, and Joel Yarney, and Richard Biritwum, and Michelle Brotzman, and Jake E Thistle, and Ernest Adjei, and Francis Aitpillah, and Florence Dedey, and Lawrence Edusei, and Nicholas Titiloye, and Baffour Awuah, and Joe Nat Clegg-Lamptey, and Beatrice Wiafe-Addai, and Verna Vanderpuye
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

Skin lighteners and hair relaxers, both common among women of African descent, have been suggested as possibly affecting breast cancer risk. In Accra and Kumasi, Ghana, we collected detailed information on usage patterns of both exposures among 1131 invasive breast cancer cases and 2106 population controls. Multivariate analyses estimated odds ratios (ORs) and 95% confidence intervals (CIs) after adjustment for breast cancer risk factors. Control usage was 25.8% for ever use of skin lighteners and 90.0% for use of hair relaxers for >1 year. The OR for skin lighteners was 1.10 (95% CI 0.93-1.32), with higher risks for former (1.21, 0.98-1.50) than current (0.96, 0.74-1.24) users. No significant dose-response relations were seen by duration, age at first use or frequency of use. In contrast, an OR of 1.58 (95% CI 1.15-2.18) was associated with use of hair relaxers, with higher risks for former (2.22, 1.56-3.16) than current (1.39, 1.00-1.93) users. Although numbers of burns were inconsistently related to risk, associations increased with duration of use, restricted to women who predominately used non-lye products (P for trend < 0.01). This was most pronounced among women with few children and those with smaller tumors, suggesting a possible role for other unmeasured lifestyle factors. This study does not implicate a substantial role for skin lighteners as breast cancer risk factors, but the findings regarding hair relaxers were less reassuring. The effects of skin lighteners and hair relaxers on breast cancer should continue to be monitored, especially given some biologic plausibility for their affecting risk.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D005869 Ghana A republic in western Africa, south of BURKINA FASO and west of TOGO. Its capital is Accra. Gold Coast,Republic of Ghana
D006203 Hair Preparations Hair grooming, cleansing and modifying products meant for topical application to hair, usually human. They include sprays, bleaches, dyes, conditioners, rinses, shampoos, nutrient lotions, etc. Cosmetics, Hair,Hair Cosmetic,Hair Preparation,Cosmetic, Hair,Hair Cosmetics,Preparation, Hair,Preparations, Hair
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Louise A Brinton, and Jonine D Figueroa, and Daniel Ansong, and Kofi M Nyarko, and Seth Wiafe, and Joel Yarney, and Richard Biritwum, and Michelle Brotzman, and Jake E Thistle, and Ernest Adjei, and Francis Aitpillah, and Florence Dedey, and Lawrence Edusei, and Nicholas Titiloye, and Baffour Awuah, and Joe Nat Clegg-Lamptey, and Beatrice Wiafe-Addai, and Verna Vanderpuye
May 2007, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Louise A Brinton, and Jonine D Figueroa, and Daniel Ansong, and Kofi M Nyarko, and Seth Wiafe, and Joel Yarney, and Richard Biritwum, and Michelle Brotzman, and Jake E Thistle, and Ernest Adjei, and Francis Aitpillah, and Florence Dedey, and Lawrence Edusei, and Nicholas Titiloye, and Baffour Awuah, and Joe Nat Clegg-Lamptey, and Beatrice Wiafe-Addai, and Verna Vanderpuye
January 2010, Breast cancer research : BCR,
Louise A Brinton, and Jonine D Figueroa, and Daniel Ansong, and Kofi M Nyarko, and Seth Wiafe, and Joel Yarney, and Richard Biritwum, and Michelle Brotzman, and Jake E Thistle, and Ernest Adjei, and Francis Aitpillah, and Florence Dedey, and Lawrence Edusei, and Nicholas Titiloye, and Baffour Awuah, and Joe Nat Clegg-Lamptey, and Beatrice Wiafe-Addai, and Verna Vanderpuye
January 1994, European journal of gynaecological oncology,
Louise A Brinton, and Jonine D Figueroa, and Daniel Ansong, and Kofi M Nyarko, and Seth Wiafe, and Joel Yarney, and Richard Biritwum, and Michelle Brotzman, and Jake E Thistle, and Ernest Adjei, and Francis Aitpillah, and Florence Dedey, and Lawrence Edusei, and Nicholas Titiloye, and Baffour Awuah, and Joe Nat Clegg-Lamptey, and Beatrice Wiafe-Addai, and Verna Vanderpuye
September 2021, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Louise A Brinton, and Jonine D Figueroa, and Daniel Ansong, and Kofi M Nyarko, and Seth Wiafe, and Joel Yarney, and Richard Biritwum, and Michelle Brotzman, and Jake E Thistle, and Ernest Adjei, and Francis Aitpillah, and Florence Dedey, and Lawrence Edusei, and Nicholas Titiloye, and Baffour Awuah, and Joe Nat Clegg-Lamptey, and Beatrice Wiafe-Addai, and Verna Vanderpuye
July 2000, International journal of cancer,
Louise A Brinton, and Jonine D Figueroa, and Daniel Ansong, and Kofi M Nyarko, and Seth Wiafe, and Joel Yarney, and Richard Biritwum, and Michelle Brotzman, and Jake E Thistle, and Ernest Adjei, and Francis Aitpillah, and Florence Dedey, and Lawrence Edusei, and Nicholas Titiloye, and Baffour Awuah, and Joe Nat Clegg-Lamptey, and Beatrice Wiafe-Addai, and Verna Vanderpuye
June 1989, Journal of epidemiology and community health,
Louise A Brinton, and Jonine D Figueroa, and Daniel Ansong, and Kofi M Nyarko, and Seth Wiafe, and Joel Yarney, and Richard Biritwum, and Michelle Brotzman, and Jake E Thistle, and Ernest Adjei, and Francis Aitpillah, and Florence Dedey, and Lawrence Edusei, and Nicholas Titiloye, and Baffour Awuah, and Joe Nat Clegg-Lamptey, and Beatrice Wiafe-Addai, and Verna Vanderpuye
January 2022, Journal of biosocial science,
Louise A Brinton, and Jonine D Figueroa, and Daniel Ansong, and Kofi M Nyarko, and Seth Wiafe, and Joel Yarney, and Richard Biritwum, and Michelle Brotzman, and Jake E Thistle, and Ernest Adjei, and Francis Aitpillah, and Florence Dedey, and Lawrence Edusei, and Nicholas Titiloye, and Baffour Awuah, and Joe Nat Clegg-Lamptey, and Beatrice Wiafe-Addai, and Verna Vanderpuye
April 2010, Breast cancer research and treatment,
Louise A Brinton, and Jonine D Figueroa, and Daniel Ansong, and Kofi M Nyarko, and Seth Wiafe, and Joel Yarney, and Richard Biritwum, and Michelle Brotzman, and Jake E Thistle, and Ernest Adjei, and Francis Aitpillah, and Florence Dedey, and Lawrence Edusei, and Nicholas Titiloye, and Baffour Awuah, and Joe Nat Clegg-Lamptey, and Beatrice Wiafe-Addai, and Verna Vanderpuye
April 2017, Health care for women international,
Louise A Brinton, and Jonine D Figueroa, and Daniel Ansong, and Kofi M Nyarko, and Seth Wiafe, and Joel Yarney, and Richard Biritwum, and Michelle Brotzman, and Jake E Thistle, and Ernest Adjei, and Francis Aitpillah, and Florence Dedey, and Lawrence Edusei, and Nicholas Titiloye, and Baffour Awuah, and Joe Nat Clegg-Lamptey, and Beatrice Wiafe-Addai, and Verna Vanderpuye
January 2021, PloS one,
Copied contents to your clipboard!